Oral semaglutide-like drugs quiet brain reward circuits and reduce mice pleasure-eating
New mouse data suggests oral GLP-1 medicines can dial down the “want it more” wiring behind food cravings.

Loading briefings
Pulling the latest in this topic…
Research, space, health, climate, discovery
246 briefings briefings in Science
New mouse data suggests oral GLP-1 medicines can dial down the “want it more” wiring behind food cravings.
Here’s the full U.S. schedule and what each night’s shark science is actually trying to prove.
A simple modeling result challenges the “I’ll just change lanes” reflex, with implications for safety, policy, and fleet costs.
A simple, gut-focused supplement reduced knee pain and pain sensitivity while improving strength, raising questions about easier adherence than digital therapy.
Scientists debate what “quasi” means, and the practical answer changes how you interpret solids, electricity, and experiments.
Regulators, boards, and clinicians want certainty, yet evidence on GLP-1 side-effects like hair loss remains uneven.
The metal lid and plastic body are stuck together, creating a recycling headache that could push regulators to act.
Europe’s top condensed matter award signals a third magnetic class, with real implications for future spintronic tech.
A successful second test of Starship’s newest design strengthens the path to the Moon, and SpaceX’s orbit data goals.
A successful Starship launch validated capabilities that matter for the economics, schedule, and regulation of human Moon missions.
Why “protecting culture” is getting a sustainability upgrade, and what decision-makers must measure when it comes to risk and cost.
Colorado State University’s work uses wound odors to improve protection for livestock and wildlife from a deadly parasite.